Definigen Competitors and Similar CompaniesClear all
Sana Biotechnology's competitors and similar companies include Editas Medicine.
 Editas Medicine Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics. | ||
Founding Date | Founding Date 2018 | Founding Date 2013 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Seattle, US HQ Cambridge, US South San Francisco, US | Locations Cambridge, US HQ Boulder, US Cambridge, US |
Employees | Employees 19441% decrease | Employees 20816% increase |
Valuation ($) | Valuation ($) 840.9 m | Valuation ($) 256.5 m |
Financial | ||
Net income | Net income ($244.2m) (FY, 2025) | Net income ($160.1m) (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 700m | Total funding raised $ 210m |
For sources of this data, please see the company profile
View Company Profiles
Editas Medicine
HQ
Cambridge, US
Employees
208↑ 16% increase
Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics.
View company